Mave Health aims to improve attention and mood with its brain-stimulating headset

San Francisco-based Mave Health has launched a $495 neuromodulation headset using transcranial direct current stimulation (tDCS) that claims to improve attention, mood, and stress regulation. Founded in 2023, the startup is positioning its product as a non-medical lifestyle device to bypass FDA clearance and reach a wider consumer audience. The founders were motivated by personal experiences with mental health challenges and a perceived lack of measurable progress tracking in traditional therapy.